WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: NOVEMBER ISSUE PUBLISHED
  • NOVEMBER 2024 Issue has been successfully launched on NOVEMBER 2024.

Abstract

DIFFERENCES IN LIPID PROFILE WITH INTERNATIONAL PRODUCT OF SIMVASTATIN AND LOCAL PRODUCT IN PATIENTS WITH PRIMARY HYPERLIPIDEMIA

Naveed Ali Siddiqui, MBBS, MPhil, Tahira Perveen, Syed Asif Jahanzeb Kazmi, Aziza Khanum, Ambreen

ABSTRACT

Objective: To compare the changes in lipid profile in patients with primary hyperlipidemia using international and local product of the lipid lowering drug, Simvastatin. Material and Methods: The study was conducted at Surgeon Munawar Memorial Hospital, Karachi in year 2009 -2011. The study was designed to evaluate the effects of simvastatin on lipid profile, and to compare the lipid lowering efficacy of international and local product of simvastatin in patients with primary hyperlipidemia. Fifty patients with abnormal lipid profile were included in the study (age 30-70 years). Patients were divided into two groups (25 patients each). Group A was orally administered with international product of simvastatin (10 mg)/day for 4 weeks and in group B, patients were orally administered with local product of simvastatin (10 mg)/day for 4 weeks. Results: The Cholesterol, Triglyceride (TG), High density lipoprotein (HDL) and Low density lipoprotein (LDL) were estimated in the serum of patients before and after treatment with international and local product of simvastatin (10mg/day). After the treatment serum Cholesterol, Triglyceride and Low density lipoprotein were decreased in both groups, both drugs were well tolerated by the subjects without any serious side effects. Conclusion: On the basis of this study we concluded that both international and local product of simvastatin are equally effective.

Keywords: Lipid profile, Hyperlipidemia, Local & International product, Simvastatin.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More